🔬 New study in Translational Research: Hu-FLT3 humanized mice better reconstitute key human innate immune cells, support HIV-1 persistence, respond to ART, and show viral rebound after treatment interruption. A useful platform for HIV cure research. 📖 www.translationalres.com/article/S193...
🎓 Big day: Irene González-Navarro successfully defended her PhD thesis at UAB on viral reservoir correlates and HIV-1 remission. 4 wonderful years at IrsiCaixa. Together with María, we wish her all the best in her scientific career 🌟🧬 Congratulations, Dr. González-Navarro!
👨🔬 It was a pleasure to host Dr. Satish Pillai at IrsiCaixa. Dr. Pillai is professor of Laboratory Medicine at the University of California, San Francisco (UCSF) and a Senior Investigator at the Vitalant Research Institute.
It was a pleasure to attend the 2026 HIV Cure Meeting (June 17–18) in Aarhus 🇩🇰 An excellent meeting bringing together scientists from across Europe.
Thanks to Dr. Galera for the invitation to give the keynote talk “Milestones in HIV Cure Research: Is This an Achievable Goal?” at the 11th Conference on Challenges in HIV, STIs, and Viral Hepatitis 2026 in Murcia. Great to share,science and medicine from IrsiCaixa in the “City of the Sun.” #HIV
Closing meeting of the EU-funded UNDINE project in Barcelona (10–11 May) after 4 years of work and 80+ scientific publications.
📡 Excited to share our new study published in eLife, the result of a close collaboration between IrsiCaixa and the CNB-CSIC. doi.org/10.7554/eLif...
Pleased to share our new publication on the Oslo patient, one of the very few documented cases of sustained HIV remission. Studying these exceptional cases helps us move from proof of concept toward realistic, scalable cure strategies for HIV. 📄 Read the article here: www.nature.com/articles/s41...
🧒🦠 What drives #LongCOVID in children? Our new @IrsiCaixa research in JCI Insight reveals: 🔹 Immune dysregulation 🔹 Reduced neutralizing antibodies 🔹 CCR6 as a potential biomarker (79% accuracy) 👉 A key step toward better diagnosis & treatments 🔗 doi.org/10.1172/jci.... #Pediatrics #Immunology
New research highlights a safer way to monitor children living with HIV when treatment is temporarily paused as part of cure oriented studies: journals.lww.com/aidsonline/a...
Big congrats to Andrea Mastrangelo for nailing his thesis defense on "“High-dimensional characterization of HIV-specific CD8 T cells in lymph nodes of HIV controllers,” at @unil! Amazing job, Andrea, and shoutout to mentor Matthieu Perreau and the awesome committee.
Thrilled to share that ScienHub hosted the post-CROI Denver 2026 event this week in the stunning Gaudí Hall, located in the former coach houses of La Pedrera—an iconic Barcelona landmark.
Honored to have delivered a keynote at today’s HIV Cure Symposium in Geneva, organized by Alexandra Calmy (HUG) and Matthieu Perreau (CHUV). Grateful for the inspiring discussions driving progress toward an HIV cure — a commitment we share at @irsicaixa.es. #HIVresearch #HIVcure
Honored to co-chair the 16th GeSIDA HIV Conference in Granada (Nov 23–26). Fantastic opening today with keynotes from Dr. Arribas and Dr. Abdel-Mohsen. More great science coming over the next 3 days!
Great to see @IrsiCaixa at the Seville conference with @CIBERINFEC and @CIBERBBN (Nov 13–14), collaborating to spark new synergies in biomedical research.
Thankful to have given the keynote on '#HIV cure: facts, fiction, and the future' at the 8th HIV Update Meeting organized by the Clinic Hospital of Barcelona (Nov 7–8)!
EU2CURE members met on June 17-18 at the AROS Art Museum in beatiful Aarhus, Denmark, to discuss scientific progress and future logistic challenges. The two-day meeting provide the opportunity to young investigators and those not-so-young 😉 to share new data and clinical trial designs.
🦠🦠🦠 Viruses take advantage of existing cellular mechanisms to spread within host organisms.
